Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.836
Bid: 0.836
Ask: 0.842
Change: -0.002 (-0.24%)
Spread: 0.006 (0.718%)
Open: 0.838
High: 0.842
Low: 0.836
Prev. Close: 0.838
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

27 Dec 2017 07:00

RNS Number : 2713A
BioPharma Credit PLC
27 December 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

BioPharma Credit PLC

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

Issue of New Shares

Yes

3. Full name of person(s) subject to thenotification obligation: iii

Inteligo Bank Ltd.

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

18 December 2017

6. Date on which issuer notified:

21 December 2017

7. Threshold(s) that is/are crossed orreached: vi, vii

8%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ORD USD0.01

Below 9%

Below 9%

78,525,801

78,525,801

0

8.59%

0.0%

GB00BDGKMY29

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

N/A

N/A

N/A

N/A

N/A

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

N/A

N/A

N/A

N/A

 

N/A

Nominal

Delta

N/A

N/A

Total (A+B+C)

Number of voting rights

Percentage of voting rights

78,525,801

8.59%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

N/A

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

14. Contact name:

Victor Vinatea / Guillermo Villanueva

15. Contact telephone number:

+507-366-9602 / +507-366-9670

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUUVORBRAUUAA
Date   Source Headline
2nd Jan 20181:00 pmRNSTotal Voting Rights
27th Dec 20172:30 pmRNSHolding(s) in Company
27th Dec 20177:00 amRNSHolding(s) in Company
14th Dec 20176:30 pmRNSResults of Placing
14th Dec 20177:00 amRNSProposed Placing of Shares
13th Dec 20174:00 pmRNSNet Asset Value(s)
11th Dec 20177:00 amRNSPotential Issue of Shares
8th Dec 20175:00 pmRNSNew Investment
7th Dec 20174:45 pmRNSDividend Declaration
5th Dec 20177:00 amRNSNew Acquisition
21st Nov 20174:00 pmRNSNet Asset Value(s)
21st Nov 20171:50 pmRNSAnnouncement of First Major Investment Since IPO
13th Nov 20174:30 pmRNSHolding(s) in Company
20th Oct 20175:00 pmRNSHolding(s) in Company
20th Oct 20174:00 pmRNSNet Asset Value(s)
21st Sep 201710:03 amRNSNet Asset Value(s)
21st Sep 20177:00 amRNSHalf-year Report
24th Aug 20173:15 pmRNSNotice of Results
22nd Aug 20173:22 pmRNSNotice of Results
21st Aug 20174:00 pmRNSNet Asset Value(s)
21st Jul 20174:00 pmRNSNet Asset Value(s)
30th Jun 20174:30 pmRNSReduction of share premium account
19th Jun 20174:00 pmRNSNet Asset Value(s)
22nd May 20174:00 pmRNSNet Asset Value(s)
3rd May 20172:05 pmRNSCorrection: Final Results of Issue
25th Apr 20174:14 pmRNSNet Asset Value(s)
12th Apr 201711:24 amRNSHolding(s) in Company
6th Apr 20176:00 pmRNSCorrection: Total Voting Rights
6th Apr 20173:45 pmRNSHolding(s) in Company
6th Apr 20173:45 pmRNSHolding(s) in Company
5th Apr 20175:30 pmRNSHolding(s) in Company
5th Apr 20174:30 pmRNSHolding(s) in Company
3rd Apr 20173:00 pmRNSTotal Voting Rights
31st Mar 20176:00 pmRNSHolding(s) in Company
31st Mar 20172:15 pmRNSDirector/PDMR Shareholding
31st Mar 20171:45 pmRNSTotal Voting Rights
30th Mar 20171:00 pmRNSDirector/PDMR Shareholding
29th Mar 201711:00 amRNSHolding(s) in Company
29th Mar 201710:30 amRNSDirector/PDMR Shareholding
28th Mar 201710:30 amRNSDirector/PDMR Shareholding
28th Mar 201710:30 amRNSDirector/PDMR Shareholding
28th Mar 201710:30 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.